written on 15.05.2014
Tags:
,

The Great Divide – Public vs Private Life Sciences Investment

TAGS: ,

The Allicense 2014 provided a unique venue in which both public and private investors engaged in a robust discussion around investing in the life sciences. We heard from seasoned investors from Frazier Healthcare, Sofinnova, and InterWest on the venture capital side, while also hearing from leaders at Franklin Templeton and EcoR1 representing public investors. Panel […]

Latest Report